PART I The following discussion contains forward-looking statements. Actual results may differ significantly from those expressed or implied in the forward-looking statements. See Cautionary Note Concerning Forward-Looking Statements on page 3 of this Annual Report. Factors that might cause future results to differ materially from those expressed or implied in the forward-looking statements include, but are not limited to, those discussed in Item 1ARisk Factors and elsewhere in this Annual Repor...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001193125-26-068925 | EDGAR | 93K words |
| 2025-02-12 | 2024-12-31 | 0000950170-25-019011 | EDGAR | — |
| 2024-02-21 | 2023-12-31 | 0000950170-24-017883 | EDGAR | — |
| 2023-02-16 | 2022-12-31 | 0001564590-23-002020 | EDGAR | — |
| 2022-02-16 | 2021-12-31 | 0001564590-22-005304 | EDGAR | — |
| 2021-02-11 | 2020-12-31 | 0001564590-21-005593 | EDGAR | — |
| 2020-02-13 | 2019-12-31 | 0001564590-20-004489 | EDGAR | — |
| 2019-02-15 | 2018-12-31 | 0001564590-19-003060 | EDGAR | — |
| 2018-02-16 | 2017-12-31 | 0001520262-18-000016 | EDGAR | — |
| 2017-02-17 | 2016-12-31 | 0001520262-17-000007 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-28 | 2025-09-30 | 0001193125-25-252524 | EDGAR | 29K words |
| 2025-07-29 | 2025-06-30 | 0000950170-25-099409 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000950170-25-061817 | EDGAR | — |
| 2024-10-24 | 2024-09-30 | 0000950170-24-116872 | EDGAR | — |
| 2024-07-24 | 2024-06-30 | 0000950170-24-085873 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0000950170-24-051397 | EDGAR | — |
| 2023-10-25 | 2023-09-30 | 0000950170-23-055178 | EDGAR | — |
| 2023-07-26 | 2023-06-30 | 0000950170-23-034725 | EDGAR | — |
| 2023-04-26 | 2023-03-31 | 0001564590-23-006240 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000950170-22-021003 | EDGAR | — |
| 2022-07-27 | 2022-06-30 | 0001564590-22-026586 | EDGAR | — |
| 2022-04-27 | 2022-03-31 | 0001564590-22-015890 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-25 | 0001193125-26-068927 | EDGAR | 2K words |
| 2026-02-25 | 0001193125-26-068512 | EDGAR | — |
| 2026-02-12 | 0001193125-26-047682 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009813 | EDGAR | — |
| 2026-01-06 | 0001193125-26-003453 | EDGAR | — |
| 2025-11-19 | 0001193125-25-286909 | EDGAR | — |
| 2025-11-12 | 0001193125-25-276161 | EDGAR | — |
| 2025-10-28 | 0001193125-25-252207 | EDGAR | — |
| 2025-10-22 | 0001193125-25-245852 | EDGAR | — |
| 2025-09-12 | 0001193125-25-202307 | EDGAR | — |
177 total filings indexed. 145 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001520262 |
| Ticker | ALKS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.alkermes.com |
| Listed | 1991-07-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report